Quick Takeaways
- Terry-Ann Burrell has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,647,956.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Terry-Ann Burrell and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | Chief Financial Officer | $3,133,858 | 26 Apr 2024 | ||
| RXRX | RECURSION PHARMACEUTICALS, INC. | Director | $514,098 | 01 Jul 2024 | ||
| RAPP | Rapport Therapeutics, Inc. | Director | 06 Jun 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|